Abstract:Background Adventitial remodeling is a pathological hallmark of hypertension that results in target organ damage. Activated adventitial fibroblasts have emerged as critical regulators in this process, but the precise mechanism remains unclear. Methods and Results Interleukin 11 (IL‐11) knockout and wild‐type mice were subjected to angiotensin II (Ang II) infusion to establish models of hypertension‐associated vascular remodeling. IL‐11 mRNA and protein were increased especially in the adventitia in response to Ang II. Compared with wild‐type mice, Ang II–treated IL‐11 knockout mice showed amelioration of vascular hypertrophy, adventitial fibrosis, macrophage infiltration, and inflammatory factor expression. Recombination mouse IL‐11 exacerbated adventitial fibrosis in Ang II–infused wild‐type mice. Interestingly, IL‐11 neutralizing antibody attenuated adventitial fibrosis, macrophage infiltration, and inflammatory factor expression after Ang II infusion for 7 days. Mechanistically, in primary cultured adventitial fibroblasts, Krüppel‐like factor 15 negatively regulated Ang II–induced IL‐11 expression. Ang II increased extracellular signal‐regulated kinases 1 and 2 activation, especially in adventitia, and caused biphasic extracellular signal‐regulated kinases 1 and 2 activation in adventitial fibroblasts. A rapid and early activation increased IL‐11 production through decreasing Krüppel‐like factor 15 expression, which, in turn, induced the second extracellular signal‐regulated kinases 1 and 2 activation, resulting in posttranscriptional profibrotic gene expression. Conclusions These results demonstrate that extracellular signal‐regulated kinases 1 and 2 activation is important for Krüppel‐like factor 15–mediated IL‐11 expression in adventitial fibroblasts to promote adventitial remodeling in Ang II–induced hypertension. Therefore, targeting the Krüppel‐like factor 15/IL‐11 axis might serve as a new therapeutic strategy for vascular diseases. Nonstandard Abbreviations and Acronyms ACTA α‐smooth muscle actin AF adventitial fibroblast Ang II angiotensin II COL1a1 collagen, type I, α 1 IL‐11 –/– interleukin 11 knockout KLF15 Krüppel‐like factor 15 rmIL‐11 recombination mouse IL‐11 WT wild type Clinical Perspective What Is New? Blockade of interleukin 11 (IL‐11) almost normalized adventitial fibrosis induced by angiotensin II. Krüppel‐like factor 15 negatively regulates IL‐11 expression, depending on extracellular signal‐regulated kinases 1 and 2 activation, which contributed to adventitial remodeling. Angiotensin II induced biphasic extracellular signal‐regulated kinases 1 and 2 activation with the second activation depending on IL‐11. What Are the Clinical Implications? Our study reveals a novel role for IL‐11 in hypertension‐associated vascular remodeling and fibrosis. We provide a possible treatment strategy for Krüppel‐like factor 15/IL‐11 axis in alleviating and reversing hypertension‐associated vascular remodeling and fibrosis. Vascular remodeling is a common consequence of hypertensive disease and contributes to the development of cardiovascular dysfunction. 1 The vessel wall is a multilayered tissue consisting of multiple cell types to regulate vascular remodeling. Rather than a supportive tissue layer, growing evidence has shown that vascular adventitia acts as an active player for maintenance of vascular function and homeostasis. 2 Indeed, excessive adventitial remodeling leads to early aortic maladaptation in angiotensin II (Ang II)–induced hypertension. 3 The main effector cells of adventitia are adventitial fibroblasts (AFs), which are activated by stress signals in injured tissues. -Abstract Truncated-

KLF11 Protects Against Abdominal Aortic Aneurysm Through Inhibition of Endothelial Cell Dysfunction.

Abstract 265: Endothelial Krüppel Like Factor 11 Inhibits Abdominal Aortic Aneurysm

KLF11 (Krüppel-Like Factor 11) Inhibits Arterial Thrombosis Via Suppression of Tissue Factor in the Vascular Wall

Smooth Muscle-Specific LKB1 Deletion Exaggerates Angiotensin II-induced Abdominal Aortic Aneurysm in Mice.

Endothelial KLF11 is a novel protector against diabetic atherosclerosis

Lysyl hydroxylase 1 (LH1) deficiency promotes angiotensin II (Ang II)-induced dissecting abdominal aortic aneurysm

Cathepsin L Activity is Essential to Elastase Perfusion–Induced Abdominal Aortic Aneurysms in Mice

AEBP1 Promotes the Occurrence and Development of Abdominal Aortic Aneurysm by Modulating Inflammation via the NF-κB Pathway

Early Progression of Abdominal Aortic Aneurysm is Decelerated by Improved Endothelial Barrier Function via ALDH2‐LIN28B‐ELK3 Signaling

Krüppel-like Factor 14, a Coronary Artery Disease Associated Transcription Factor, Inhibits Endothelial Inflammation Via NF-κB Signaling Pathway.

Abstract 468: HIF-1α Mediates Initiation and Progression of Experimental Abdominal Aortic Aneurysms

Krüppel-Like Factor 15/Interleukin 11 Axis-Mediated Adventitial Remodeling Depends on Extracellular Signal-Regulated Kinases 1 and 2 Activation in Angiotensin II-Induced Hypertension.

MKL1 cooperates with p38MAPK to promote vascular senescence, inflammation, and abdominal aortic aneurysm

BAF60a Deficiency in Vascular Smooth Muscle Cells Prevents Abdominal Aortic Aneurysm by Reducing Inflammation and Extracellular Matrix Degradation

Effects of KLF11 on Vascular Smooth Muscle Cells and its Underlying Mechanisms in Intracranial Aneurysm

KLF15 maintains contractile phenotype of vascular smooth muscle cells and prevents thoracic aortic dissection by interacting with MRTFB

TRPV5 Attenuates Abdominal Aortic Aneurysm in Mice by Regulating KLF4-dependent Phenotype Switch of Aortic Vascular Smooth Muscle Cells.

TGF-beta Activity Protects Against Inflammatory Aortic Aneurysm Progression and Complications in Angiotensin II-infused Mice.

Abstract 142: Transgenic Overexpression of Krüppel-Like Factor 11 in Endothelium Ameliorates Ischemic Brain Injury

Disruption of PCSK9 Suppresses Inflammation and Attenuates Abdominal Aortic Aneurysm Formation

BAF60c prevents abdominal aortic aneurysm formation through epigenetic control of vascular smooth muscle cell homeostasis